by Alex Bajjon | Jan 1, 2016 | Briefings, UK
Consideration is generally held to be something of value exchanged between parties in order for a contract to be valid and enforceable. Agreements without consideration are deemed to be mere gratuitous promises and are not enforceable by law. As a standard term, most...
by David Eyre | Jan 1, 2016 | US & International
The origin of the PTE system flows from a desire to compensate those who have invested time and resources in making or finding new medical products for the additional burden of gaining regulatory approval for that product. Thus, originally, the PTE provisions were...
by | Oct 1, 2015 | Briefings, UK
Warner-Lambert is proprietor of a European patent (EP 0641330) which claims the compound pregabalin (via compound per se claims). The Supplementary Protection Certificate (SPC) was (surprisingly) allowed to lapse in October 2013 for non-payment of fees resulting in...
by Alex Bajjon | Aug 1, 2015 | UK
Warner-Lambert is the proprietor of European Patent 0934061 which claims “Use of Pregablin for the preparation of a pharmaceutical composition for treating pain”. Pregablin is also used for the treatment of generalised anxiety disorder and epilepsy, although treatment...
by George Schlich | May 1, 2015 | EPO
Background Applicants wishing to obtain patent protection in more than one country have various options for doing so. One strategy is to file a first application at, say, the UK Intellectual Property Office (UKIPO) or the European Patent Office (EPO), and then file a...
Recent Comments